Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-17

Clinical Trial Update: Study for the Treatment of Heart Failure With Preserved Ejection Fraction Associated With High Blood Pressure Using Right Atrial Pacing Controlled by the PressurePaceTM System [NA]

View source ↗

Summary

A BaroPace Inc. clinical trial evaluating the PressurePace System for treating heart failure with preserved ejection fraction associated with hypertension has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PressurePace System

Snippet

Sponsor: BaroPace Inc. | Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF), Hypertension | NA | Status: COMPLETED